Table 4 Logistic regression analyses of ancillary features in LI-RADS v2018 for LR3/LR4 observations
Variables | Univariable analysis | Multivariable analysis | ||||
|---|---|---|---|---|---|---|
Beta | OR (95%CI) | P | aBeta | aOR (95%CI) | aP | |
Nodule-in-nodule architecture | -16.78 | 0.00 (0.00 - Inf) | 0.980 | -16.81 | 0.00 (0.00 - Inf) | 0.994 |
Nonenhancing “capsule” | -14.69 | 0.00 (0.00 - Inf) | 0.987 | |||
Mosaic architecture | -1.53 | 0.22 (0.07–0.67) | 0.038 | -2.34 | 0.10 (0.01–0.69) | 0.02 |
Blood products in mass | -17.87 | 0.00 (0.00 - Inf) | 0.983 | |||
Fat in mass | -1.53 | 0.22 (0.07–0.67) | 0.008 | -2.42 | 0.09 (0.01–0.86) | 0.036 |
Subthreshold growth | 14.46 | 1903499.57 (0.00 - Inf) | 0.987 | |||
Restricted diffusion | 1.51 | 4.52 (2.52–8.10) | < 0.001 | 1.89 | 6.64 (2.70–16.30) | < 0.001 |
Mild–moderate T2 hyperintensity | 1.44 | 4.23 (2.50–7.17) | < 0.001 | 0.18 | 1.19 (0.49–2.88) | 0.695 |
Coronal enhancement | -0.61 | 0.54 (0.24–1.21) | 0.135 | |||
Fat sparing | 0.19 | 1.21 (0.55–2.67) | 0.631 | |||
Iron sparing | -2.11 | 0.12 (0.01–1.00) | 0.050 | -2.04 | 0.13 (0.01–1.36) | 0.089 |
Transitional-phase hypointensity | -1.04 | 0.35 (0.19–0.65) | < 0.001 | -0.88 | 0.42 (0.06–3.10) | 0.393 |
Hepatobiliary-phase hypointensity | -0.94 | 0.39 (0.22–0.70) | 0.001 | 0.00 | 1.00 (0.14–7.13) | 1.000 |
Parallels blood pool enhancement | 1.58 | 4.85 (1.37–17.15) | 0.014 | 0.57 | 1.76 (0.31–9.97) | 0.521 |
Undistorted vessels | -1.75 | 0.17 (0.02–1.50) | 0.111 | |||
Marked T2 hyperintensity | 2.96 | 19.37 (4.55–82.38) | < 0.001 | 3.42 | 30.44 (4.52–205.11) | < 0.001 |
HBP isointensity | 2.26 | 9.59 (2.84–32.42) | < 0.001 | 1.73 | 5.62 (1.39–22.73) | 0.016 |